Home › Companies › Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical › Inversago Pharma
Inversago Pharma
Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists
Operating in biopharma, biotechnology, health care, medical, pharmaceutical, Inversago Pharma was founded in 2015.
The company sits in the biopharma, biotechnology, health care, medical, pharmaceutical segment, where it competes on its core product or service.
Its current recorded stage is Series_C.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $111.3M.
| Sector | Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical |
|---|---|
| Founded | 2015 |
| Employees | c_00011_00050 |
| Stage | series_c |
| Total funding | $111,264,701 |
Website: inversago.com/en
Browse related
Sign in to view the contact information we hold for Inversago Pharma.
Create a free account
Create a free account